generic semaglutide vs ozempic coming to Canada: what the patent expiry means for people with diabetes – Endor Health Canada Approves First Generic Ozempic,

Changes to eyesight Sudden changes to your eyesight If you notice a sudden loss of vision or rapidly worsening eyesight during treatment with semaglutide, urgently contact your doctor

(Most of the reform was ultimately abandoned after a series of successful court challenges, of which Novo Nordisk Canada was a party.) Thomas Digby, a B.C.-based intellectual-property lawyer and chair of the review board from 2023 to 2025, said that if its true that Novo abandoned its Ozempic/Wegovy patent in order to avoid PMPRB review, choosing instead to face generic entry, then its completely unprecedented in my experience, and quite possibly a strategic business mistake. Patent protections will lapse in India and Brazil in March, and in China and Turkey later in the year

Additionally, improvements in cardiovascular risk factors were observed

This will help lessen any digestive issues

If not, your provider will suggest alternative FDA-approved cash pay GLP-1 options